• Processa Pharmaceuticals today appointed biotechnology executive Gregory J. Flesher as chief operating officer.
• Craig Coburn, a scientist who helped invent VT-7208, was named executive vice president and head of research.
• Ashley Hall was appointed executive vice president, development.
• Michael P. Cruse was named executive vice president, business operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040800PRIMZONEFULLFEED9869707) on November 04, 2026, and is solely responsible for the information contained therein.